Biologic and therapeutic role of HER2 in cancer

Oncogene

Volumn 22, Issue 43, 2003, Pages 6570-6578

  Ménard, Sylvie ^a   Pupa, Serenella Marja ^a   Campiglio, Manuela ^a   Tagliabue, Elda ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Biological role; HER2; Predictive value; Prognostic value; Therapy

Indexed keywords

ANTIESTROGEN; ANTINEOPLASTIC AGENT; CANCER VACCINE; CYCLOPHOSPHAMIDE; DNA VACCINE; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GEFITINIB; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; METHOTREXATE; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR; TAMOXIFEN; TRASTUZUMAB;

ANIMAL CELL; ANIMAL MODEL; BREAST CARCINOMA; CANCER; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TARGETING; FEMALE; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; IMMUNOTHERAPY; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TRANSGENIC MOUSE; TREATMENT OUTCOME; TUMOR GROWTH; VACCINATION;

ANIMALIA; MUS MUSCULUS;

EID: 0242624620     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206779     Document Type: Review

References (137)

1. Cell Markers and Cytogenetics Committees College of American Pathologist. (2002). Arch. Pathol. Lab. Med. 126, 803-808.
2. Allgayer H, Babic R, Gruetzner KU, Tarabichi A, Schildberg FW and Heiss MM. (2000). J. Clin. Oncol., 18, 2201-2209.
3. Amici A, Smorlesi A, Noce G, Santoni G, Cappelletti P, Capparuccia L, Coppari R, Lucciarini R, Petrelli C and Provinciali M. (2000). Gene Therapy, 7, 703-706.
4. Bocchia M, Bronte V, Colombo MP, De Vincentiis A, Di Nicola M, Forni G, Lanata L, Lemoli RM, Massaia M, Rondelli D, Zanon P and Tura S. (2000). Haematologica, 85, 1172-1206.
5. Bocker W, Moll R, Poremba C, Holland R, Van Diest PJ, Dervan P, Burger H, Wai D, Ina DR, Brandt B, Herbst H, Schmidt A, Lerch MM and Buchwallow IB. (2002). Lab. Invest., 82, 737-746.
6. Burstein HJ, Harris LN, Gelman R, Lester SC, Nunes RA, Kaelin CM, Parker LM, Ellisen LW, Kuter I, Gadd MA, Christian RL, Kennedy PR, Borges VF, Bunnell CA, Younger J, Smith BL and Winer EP. (2003). J. Clin. Oncol., 21, 46-53.
7. Campiglio M, Somenzi G, Olgiati C, Beretta G, Balsari A, Zaffaroni N, Valagussa P and Ménard S. (2003). Int. J. Cancer, 105, 568-573.
8. Campiglio M, Tagliabue E, Uppugunduri S, Pellegrini R, Martignone S, Ménard S, Colnaghi MI, Lombardi L and Marchisio PC. (1994). J. Cell. Biochem., 55, 409-418.
9. Carter P, Presta L, Gorman CM, Ridgway JB, Henner D, Wong WL, Rowland AM, Kotts C, Carver ME and Shepard HM. (1992). Proc. Natl. Acad. Sci. USA, 89, 4285-4289.
10. Casalini P, Botta L and Ménard S. (2001). J. Biol. Chem., 276, 12449-12453.
11. Cavallo F, Di Carlo E, Butera M, Verrua R, Colombo MP, Musiani P and Forni G. (1999). Cancer Res., 59, 414-421.
12. Cavallo F, Signorelli P, Giovarelli M, Musiani P, Modesti A, Brunda MJ, Colombo MP and Forni G. (1997). J. Natl. Cancer Inst., 89, 1049-1058.
13. Cefai D, Morrison BW, Sckell A, Favre L, Balli M, Leunig M and Gimmi CD. (1999). Int. J. Cancer, 83, 393-400.
14. Clynes RA, Towers TL, Presta LG and Ravetch JV. (2000). Nat. Med., 6, 443-446.
15. Cobleigh MA, Vogel CL, Tripathy D, Robert NJ, Scholl S, Fehrenbacher L, Wolter JM, Paton V, Shak S, Lieberman G and Slamon DJ. (1999). J. Clin. Oncol., 17, 2639-2648.
16. Colombo MP and Forni G. (1996). Cancer Metastasis Rev., 15, 317-328.
17. Cooke T, Reeves J, Lannigan A and Stanton P. (2001). Eur. J. Cancer, 37, 3-10.
18. Coussens L, Yang-Feng TL, Liao Y-C, Chen E, Gray A, McGrath J, Seeburg PH, Libermann FA, Schlessinger J, Francke U, Levinson A and Ullrich A. (1985). Science, 230, 1132-1139.
19. Dakappagari NK, Douglas DB, Triozzi PL, Stevens VC and Kaumaya PT. (2000). Cancer Res., 60, 3782-3789.
20. Daly JM, Jannot CB, Beerli RR, Graus-Porta D, Maurer FG and Hynes NE. (1997). Cancer Res., 57, 3804-3811.
21. Daly JM, Olayioye MA, Wong AM, Neve R, Lane HA, Maurer FG and Hynes NE. (1999). Oncogene, 18, 3440-3451.
22. De Santes K, Slamon D, Anderson SK, Shepard M, Fendly B, Maneval D and Press O. (1992). Cancer Res., 52, 1916-1923.
23. De Vecchi R, Pupa SM, Ménard S and Lollini P-L. (1999). Cancer Res., 59, 4471-4472.
24. Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK and Brugge JS. (2002). Cell, 111, 29-40.
25. Di Carlo E, Rovero S, Boggio K, Quaglino E, Amici A, Smorlesi A, Forni G and Musiani P. (2001). Clin. Cancer Res., 7, 830s-837s.
26. Di Fiore PP, Pierce JH, Kraus MH, Segatto O, King CR and Aaronson SA. (1987). Science, 237, 178-182.
27. Di Leo A, Gancberg D, Larsimont D, Tanner M, Jarvinen T, Rouas G, Dolci S, Leroy JY, Paesmans M, Isola J and Piccart MJ. (2002). Clin. Cancer Res., 8, 1107-1116.
28. Disis ML, Calenoff E, McLaughlin G, Murphy AE, Chen W, Groner B, Jeschke M, Lydon N, McGlynn E, Livingston RB, Moe R and Cheever MA. (1994). Cancer Res., 54, 16-20.
29. Disis ML and Cheever MA. (1997a). Adv. Cancer Res., 71, 343-371.
30. Disis ML, Gooley TA, Rinn K, Davis D, Piepkorn M, Cheever MA, Knutson KL and Schiffman K. (2002). J. Clin. Oncol., 20, 2624-2632.
31. Disis ML, Pupa SM, Gralow JR, Dittadi R, Ménard S and Cheever MA. (1997b). J. Clin. Oncol., 15, 3363-3367.
32. Dittmar T, Husemann A, Schewe Y, Nofer JR, Niggemann B, Zanker KS and Brandt BH. (2002). FASEB J., 16, 1823-1825.
33. Early Breast Cancer Trialists' Collaborative Group.. (1998). Lancet, 351, 1451-1467.
34. Eccles SA. (2000). Recent Results Cancer Res., 157, 41-54.
35. Elledge RM, Green S, Ciocca D, Pugh R, Allred DC, Clark GM, Hill J, Ravdin P, O'Sullivan J, Martino S and Osborne CK. (1998). Clin. Cancer Res., 4, 7-12.
36. Esserman LJ, Lopez T, Montes R, Bald LN, Fendly BM and Campbell MJ. (1999). Cancer Immunol. Immunother., 47, 337-342.
37. Feldner JC and Brandt BH. (2002). Exp. Cell Res, 272, 93-108.
38. Fendly BM, Winget M, Hudziak RM, Lipari MT, Napier MA and Ullrich A. (1990). Cancer Res., 50, 1550-1558.
39. Finn OJ and Forni G. (2002). Curr. Opin. Immunol., 14, 172-177.
40. Forni G, Lollini PL, Musiani P and Colombo MP. (2000). Cancer Res., 60, 2571-2575.
41. Foy TM, Fanger GR, Hand S, Gerard C, Bruck C and Cheever MA. (2002). Semin. Oncol., 29, 53-61.
42. Franklin WA, Veve R, Hirsch FR, Helfrich BA and Bunn Jr PA. (2002). Semin. Oncol, 29, 3-14.
43. Gambaletta D, Marchetti A, Benedetti L, Mercuric AM, Sacchi A and Falcioni R. (2000). J. Biol. Chem., 275, 10604-10610.
44. Gancberg D, Jarvinen T, Di Leo A, Rouas G, Cardoso F, Paesmans M, Verhest A, Piccart MJ, Isola J and Larsimont D. (2002). Breast Cancer Res Treat., 74, 113-120.
45. Gassmann M, Casagranda F, Orioli D, Simon H, Lai C, Klein R and Lemke G. (1995). Nature, 378, 390-394.
46. Geddert H, Zeriouh M, Wolter M, Heise JW, Gabbert HE and Sarbia M. (2002). Am. J. Clin Pathol., 118, 60-66.
47. Giani C, Casalini P, Pupa SM, De Vecchi R, Ardini E, Colnaghi MI, Giordano A and Ménard S. (1998). Oncogene, 17, 425-432.
48. Goebel SU, Iwamoto M, Raffeld M, Gibril F, Hou W, Serrano J and Jensen RT. (2002). Cancer Res., 62, 3702-3710.
49. Graus-Porta D, Beerli RR, Daly JM and Hynes NE. (1997). EMBO J., 16, 1647-1655.
50. Grunt TW, Saceda M, Martin MB, Lupu R, Dittrich E, Krupitza G, Harant H, Huber H and Dittrich C. (1995). Int. J. Cancer, 63, 560-567.
51. Harari D and Yarden Y. (2000). Oncogene, 19, 6102-6114.
52. Haynes NM, Trapani JA, Teng MW, Jackson JT, Cerruti L, Jane SM, Kershaw MH, Smyth MJ and Darcy PK. (2002). Blood, 100, 3155-3163.
53. Hieken TJ, Mehta RR and Shilkaitis A. (1996). Proc. Annu. Meet. Am. Soc. Clin. Oncol., 15, 113.
54. Hirsch FR, Varella-Garcia M, Franklin WA, Veve R, Chen L, Helfrich B, Zeng C, Baron A and Bunn Jr PA. (2002). Br. J. Cancer, 86, 1449-1456.
55. Huang GC, Hobbs S, Walton M and Epstein RJ. (2002). Br. J. Cancer, 86, 1104-1109.
56. Hudziak RM, Lewis GD, Winget M, Fendly BM, Shepard HM and Ullrich A. (1989). Mol. Cell. Biol., 9, 1165-1172.
57. Izumi Y, Xu L, di Tomaso E, Fukumura D and Jain RK. (2002). Nature, 416, 279-280.
58. Jager E, Jager D and Knuth A. (2002). Curr. Opin. Immunol., 14, 178-182.
59. Karunagaran D, Tzahar E, Beerli RR, Chen XM, Graus-Porta D, Ratzkin BJ, Seger R, Hynes NE and Yarden Y. (1996). EMBO J., 15, 254-264.
60. Kerbel RS, Viloria-Petit A, Klement G and Rak J. (2000). Eur. J. Cancer, 36, 1248-1257.
61. Khan AJ, King BL, Smith BD, Smith GL, DiGiovanna MP, Carter D and Haffty BG. (2002). Clin. Cancer Res., 8, 540-548.
62. Kiessling R, Weil WZ, Herrmann F, Lindencrona JA, Choudhury A, Kono K and Seliger B. (2002). Adv. Cancer Res., 85, 101-144.
63. Kim S, Iizuka K, Aguila HL, Weissman IL and Yokoyama WM. (2000). Proc. Natl. Acad. Sci. USA, 97, 2731-2736.
64. Knutson KL, Schiffman K and Disis ML. (2001). J. Clin. Invest., 107, 477-484.
65. Konecny G, Pauletti G, Pegram M, Untch M, Dandekar S, Aguilar Z, Wilson C, Rong HM, Bauerfeind I, Felber M, Wang HJ, Beryt M, Seshadri R, Hepp H and Slamon DJ. (2003). J. Natl. Cancer Inst., 95, 142-153.
66. Kraus MH, Issing W, Miki T, Popescu NC and Aaronson SA. (1989). Proc. Natl. Acad. Sci. USA, 86, 9193-9197.
67. Latif Z, Watters AD, Bartlett JM, Underwood MA and Aitchison M. (2002). BJU Int., 89, 5-9.
68. Lee K-F, Simon H, Chen H, Bates B, Hung M-C and Hauser C. (1995). Nature, 378, 394-398.
69. Liu Y, El-Ashry D, Chen D, Ding IYF and Kern FG. (1995). Breast Cancer Res. Treat., 34, 97-117.
70. Lollini PL and Forni G. (2002). Cancer Immunol. Immunother., 51, 409-416.
71. Ludewig B, Ochsenbein AF, Odermatt B, Paulin D, Hengartner H and Zinkernagel RM. (2000). J. Exp. Med., 191, 795-804.
72. Masood S and Bui MM. (2002). Microsc. Res. Tech., 59, 102-108.
73. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST, Kast WM and DeLeo AB. (1995). Nat. Med., 1, 1297-1302.
74. Ménard S, Balsari A, Casalini P, Tagliabue E, Campiglio M, Bufalino R and Cascinelli N. (2002). Clin. Cancer Res., 8, 520-525.
75. Ménard S, Casalini P, Campiglio M, Pupa SM, Agresti R and Tagliabue E. (2001a). Ann. Oncol., 12, S15-S19.
76. Ménard S, Forti S, Castiglioni F, Agresti R and Balsari A. (2001b). Oncology, 61, 67-72.
77. Ménard S, Pupa SM, Casalini P, Rilke F and Colnaghi MI. (1996). J. Clin. Oncol., 14, 2407.
78. Ménard S, Tagliabue E, Campiglio M and Pupa SM. (2000). J. Cell. Physiol., 182, 150-162.
79. Ménard S, Valagussa P, Pilotti S, Gianni L, Biganzoli E, Boracchi P, Tomasic G, Casalini P, Marubini E, Colnaghi MI, Cascinelli N and Bonadonna G. (2001c). J. Clin. Oncol., 19, 329-335.
80. Meyer D and Birchmeier C. (1995). Nature, 378, 386-390.
81. Miles DW, Harris WH, Gillett CE, Smith P and Barnes DM. (1999). Int. J. Cancer, 84, 354-359.
82. Moliterni A, Ménard S, Valagussa P, Biganzoli E, Boracchi P, Balsari A, Casalini P, Tomasic G, Marubini E, Pilotti S and Bonadonna G. (2003). J. Clin. Oncol., 21, 458-462.
83. Murthy SM, Goldschmidt RA, Rao LN, Ammirati M, Buchmann T and Scanlon EF. (1989). Cancer, 64, 2035-2044.
84. Muthuswamy SK, Li D, Lelievre S, Bissell MJ and Brugge JS. (2001). Nat. Cell. Biol., 3, 785-792.
85. Nagata Y, Furugen R, Hiasa A, Ikeda H, Ohta N, Furukawa K, Nakamura H, Kanematsu T and Shiku H. (1997). J. Immunol., 159, 1336-1343.
86. Nakamura H, Saji H, Ogata A, Hosaka M, Hagiwara M, Kawasaki N and Kato H. (2003). Int. J. Cancer, 103, 61-66.
87. Nanni P, Forni G and Lollini PL. (1999). Ann. Oncol., 10, 261-266.
88. Nanni P, Nicoletti G, De Giovanni C, Landuzzi L, Di Carlo E, Cavallo F, Pupa SM, Rossi I, Colombo MP, Ricci C, Astolfi A, Musiani P, Forni G and Lollini P-L. (2001). J. Exp. Med., 194, 1-12.
89. Nicolini G, Miloso M, Moroni MC, Beguinot L and Scotto L. (1996). J. Biol. Chem., 271, 30290-30296.
90. O-charoenrat P, Rhys-Evans P, Court WJ, Box GM and Eccles SA. (1999). Clin. Exp. Metastasis, 17, 631-639.
91. Ohashi PS and DeFranco AL. (2002). Curr. Opin. Immunol., 14, 744-759.
92. Paik S, Bryant J, Tan-Chiu E, Romond E, Hiller W, Park K, Brown A, Yothers G, Anderson S, Smith R, Wickerham DL and Wolmark N. (2002). J. Natl. Cancer Inst., 94, 852-854.
93. Paik SM, Bryant J, Park CH, Fisher B, Tan-Chiu E, Hyams D, Fisher ER, Lippman ME, Wickerham DL and Wolmark N. (1998). J. Natl. Cancer Inst., 90, 1361-1370.
94. Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Ben Levy R and Yarden Y. (1992). Cell, 69, 205-216.
95. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO and Botstein D. (2000). Nature, 406, 747-752.
96. Pierce JH, Arnstein P, DiMarco E, Artrip J, Kraus MH, Lonardo F, Di Fiore PP and Aaronson SA. (1991). Oncogene, 6, 1189-1194.
97. Plowman GD, Green JM, Culouscou J-M, Carlton GW, Rothwell VM and Buckley S. (1993). Nature, 366, 473-475.
98. Prenzel N, Fischer OM, Streit S, Hart S and Ullrich A. (2001). Endocr. Relat. Cancer, 8, 11-31.
99. Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma YL, Hung G, Robinson RA, Harris C, El-Naggar A, Slamon DJ, Phillips RN, Ross JS, Wolman SR and Flom KJ. (1997). J. Clin. Oncol., 15, 2894-2904.
100. Press MF, Cordon-Cardo C and Slamon DJ. (1990). Oncogene, 5, 593-962.
101. Pupa SM, Bufalino R, Invernizzi AM, Andreola S, Rilke F, Lombardi L, Colnaghi MI and Ménard S. (1996). J. Clin. Oncol., 14, 85-94.
102. Pupa SM, Invernizzi AM, Forti S, Nanni P, Lollini PL, Meazza R, Ferrini S and Ménard S. (2001). Gene Therapy, 8, 75-79.
103. Pupa SM, Ménard S, Andreola S and Colnaghi MI. (1993). Cancer Res., 53, 5864-5866.
104. Rhodes A, Jasani B, Anderson E, Dodson AR and Balaton AJ. (2002). Am. J. Clin. Pathol., 118, 408-417.
105. Rilke F, Colnaghi MI, Cascinelli N, Andreola S, Baldini MT, Bufalino R, Della Porta G, Ménard S, Pierotti MA and Testori A. (1991). Int. J. Cancer, 49, 44-49.
106. Roche PC, Suman VJ, Jenkins RB, Davidson NE, Martino S, Kaufman PA, Addo FK, Murphy B, Ingle JN and Perez EA. (2002). J. Natl. Cancer Inst., 94, 855-857.
107. Ross JS, Muraca PJ and Jaffe D. (1998). Mod. Pathol., 11, 26a.
108. Rovero S, Amici A, Carlo ED, Bei R, Nanni P, Quaglino E, Porcedda P, Boggio K, Smorlesi A, Lollini PL, Landuzzi L, Colombo MP, Giovarelli M, Musiani P and Forni G. (2000). J. Immunol., 165, 5133-5142.
109. Sarup JC, Johnson RM, King KL, Fendly BM, Lipari MT, Napier MA, Ullrich A and Shepard HM. (1991). Growth Regul., 1, 72-82.
110. Sfondrini L, Besusso D, Rumio C, Rodolfo M, Menard S and Balsari A. (2002). FASEB J., 16, 1749-1754.
111. Shepard HM, Lewis GD, Sarup JC, Fendly BM, Maneval D, Mordenti J, Figari I, Kotts CE, Palladino MAJ and Ullrich A. (1991). J. Clin. Immunol., 11, 117-127.
112. Sibilia M, Steinbach JP, Stingl L, Aguzzi A and Wagner EF. (1998). EMBO J., 17, 719-731.
113. Sieweke MH and Bissell MJ. (1994). Crit. Rev. Oncog., 5, 297-311.
114. Sirotnak FM, Zakowski MF, Miller VA, Scher HI and Kris MG. (2000). Clin. Cancer Res., 6, 4885-4892.
115. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SC, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press MF. (1989). Science, 244, 707-712.
116. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J and Norton L. (2001). N. Engl. J. Med., 344, 783-792.
117. Sliwkowski MX, Lofgren JA, Lewis GD, Hotaling TE, Fendly BM and Fox JA. (1999). Semin. Oncol., 26, 60-70.
118. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein LP and Borresen-Dale AL. (2001). Proc. Natl. Acad. Sci. USA, 98, 10869-10874.
119. Soule S, Baldridge L, Kirkpatrick K, Cheng L, Gilbert JL, Smith LR, Thurston VC, Vance GH, Einhorn L and Miller K. (2002). J. Clin. Pathol., 55, 656-658.
120. Tagliabue E, Agresti R, Ghirelli C, Morelli D and Ménard S. (2001). Breast Cancer Res. Treat., 70, 155-156.
121. Tagliabue E, Ardini E, Pellegrini R, Campiglio M, Bufalino R, Jeschke M, Groner B, Colnaghi MI and Ménard S. (1996). Br. J. Cancer, 74, 1427-1433.
122. Tagliabue E, Pilotti S, Gianni AM, Ménard S and Colnaghi MI. (1998). Eur. J. Cancer, 34, 1982-1983.
123. Tan M, Yao J and Yu DH. (1997). Cancer Res., 57, 1199-1205.
124. Thor AD, Berry DA, Budman DR, Muss HB, Kute T, Henderson IC, Barcos M, Cirrincione C, Edgerton S, Allred C, Norton L and Liu ET. (1998). J. Natl. Cancer Inst., 90, 1346-1360.
125. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K and Harris RC. (1995). Science, 269, 230-234.
126. Tsavaris N, Kosmas C, Vadiaka M, Kanelopoulos P and Boulamatsis D. (2002). Br. J. Cancer, 87, 21-27.
127. Tzahar E, Waterman H, Chen X, Levkowitz G, Karunagaran D, Lavi S, Ratzkin BJ and Yarden Y. (1996). Mol. Cell. Biol., 16, 5276-5287.
128. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD and Seeburg PH. (1984). Nature, 309, 418-425.
129. Van'T Veer LJ, Dai H, Van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R and Friend SH. (2002). Nature, 415, 530-536.
130. Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, Slamon DJ, Murphy M, Novotny WF, Burchmore M, Shak S, Stewart SJ and Press M. (2002). J. Clin. Oncol., 20, 719-726.
131. Volpi A, De Paola F, Nanni O, Granato AM, Bajorko P, Becciolini A, Scarpi E, Riccobon A, Balzi M and Amadori D. (2000). Breast Cancer Res. Treat., 63, 181-192.
132. Waterman H, Alroy I, Strano S, Seger R and Yarden Y. (1999). EMBO J., 18, 3348-3358.
133. Witters L, Engle L and Lipton A. (2002). Oncol Rep., 9, 1163-1166.
134. Yan J, Fang Y, Huang BJ, Liang QW, Wu QL and Zeng YX. (2002). Cancer Genet. Cytogenet., 132, 116-119.
135. Yarden Y. (2001). Eur. J. Cancer, 37, S3-S8.
136. Zhou BP and Hung MC. (2002). Semin. Oncol., 29, 62-70.
137. Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT and Storkus WJ. (1996). J. Exp. Med., 183, 87-97.